Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Tzina Lindenberg"'
Autor:
Tzina Lindenberg, Amicur Farkas, Harry J. Hirsch, Irving M. Spitz, Hadassa Gelber, David Gillis, David Strich, Boris Chertin
Publikováno v:
Pediatrics. 116:e798-e802
Objective. Standard treatment of central precocious puberty (CPP) consists of intramuscular or subcutaneous administration of a gonadotropin-releas- ing hormone (GnRH) agonist (GnRHa) at 3- to 4-week intervals. Although generally effective in suppres
Autor:
Avraham Ben-Chetrit, Irving M. Spitz, David Zacut, Talia Eldar-Geva, Tzina Lindenberg, Morshed Farhat, Regine Sitruk-Ware, Hadassa Gelber, Shlomo Shimonovitz
Publikováno v:
Human Reproduction. 19:2372-2376
BACKGROUND: Many techniques have been developed to soften the cervix to reduce complications following surgical dilatation. Progesterone inhibits myometrial contractility and its secretion during pregnancy ensures cervical competence. We used the pro
Autor:
Vanessa R. Panz, Barry I Joffe, Amicur Farkas, Tzina Lindenberg, Mohammed Haffejee, Irving M. Spitz
Publikováno v:
Endocrine. 15:213-216
The most common malignancy in men worldwide is cancer of the prostate. Androgens play a direct role in normal and malignant growth of prostate cells via the androgen receptor (AR). This study analyzed the polymorphic CAG repeat sequence in exon 1 of
Autor:
Tzina Lindenberg, Irving M. Spitz, Regine Sitruk-Ware, Hadassa Gelber, Nathalie Chabbert-Buffet, Steven M. Grunberg
Publikováno v:
Fertility and sterility. 84(6)
Objective To determine clinical side effects and biochemical and hematological abnormalities in patients with nonresectable meningioma on long-term mifepristone (RU 486) therapy. Design Long-term mifepristone administration in patients with meningiom
Autor:
Tzina Lindenberg, Chavie Leiter, Amicur Farkas, Irving M. Spitz, Dmitry Koulikov, Hadassa Gelber, Alon Fridmans, Boris Chertin
Publikováno v:
The Journal of urology. 173(3)
Purpose: We determined the duration of testosterone suppression and recovery in patients with prostate cancer treated with a hydrogel implant releasing the gonadotropin releasing hormone (GnRH) agonist histrelin or treated with a depot GnRH agonist.
Autor:
Amicur Farkas, Irving M. Spitz, Nurit Algur, Tzina Lindenberg, Alfred J. Moo Young, Boris Chertin, Tami Zer, Petr Kuzma, Raphael Catane
Publikováno v:
The Journal of urology. 163(3)
Purpose: The administration of gonadotropin hormone-releasing hormone agonists is well established for treating metastatic prostate cancer. In an ongoing study we evaluated the effect of a long acting implant that releases the gonadotropin hormone-re
Publikováno v:
New England Journal of Medicine. 340:1439-1439
To the Editor: Medical castration with long-acting gonadotropin-releasing hormone agonists is an effective therapy for men with metastatic prostate cancer.1,2 Initially, these agonists had to be gi...